TCELL SCIENCES FORM SC 13D

Company

Celldex Therapeutics, Inc.

Filed

May 21, 1998

Accession Number

0001029869-98-000713

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →